EMPIRE BIO A/S
CVR number: 12627343
Guldbergsgade 29 F, 2200 København N
tel: 35395288
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 10 820.62 | 6 733.64 | 6 071.77 | 6 158.89 | 6 139.57 |
| Employee benefit expenses | -5 632.16 | -5 180.72 | -5 039.10 | -5 434.25 | -5 541.29 |
| Total depreciation | - 828.87 | - 931.83 | - 830.79 | - 806.96 | - 869.29 |
| EBIT | 4 359.59 | 621.09 | 201.88 | -82.32 | - 271.01 |
| Other financial expenses | -82.67 | -35.57 | -41.84 | -28.86 | |
| Pre-tax profit | 4 276.92 | 585.52 | 160.04 | - 111.18 | - 271.01 |
| Income taxes | - 942.37 | - 133.90 | -34.75 | 26.53 | 61.00 |
| Net earnings | 3 334.56 | 451.62 | 125.29 | -84.64 | - 210.01 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 5 184.92 | 4 664.86 | 4 541.60 | 3 937.68 | 3 956.10 |
| Machinery and equipment | 267.79 | 254.05 | 214.28 | 267.46 | 386.60 |
| Tangible assets total | 5 452.70 | 4 918.91 | 4 755.88 | 4 205.14 | 4 342.70 |
| Other receivables | 750.95 | 765.58 | 780.50 | 800.26 | 839.31 |
| Investments total | 750.95 | 765.58 | 780.50 | 800.26 | 839.31 |
| Long term receivables total | |||||
| Finished products/goods | 499.97 | 248.39 | 349.47 | 369.43 | 296.50 |
| Inventories total | 499.97 | 248.39 | 349.47 | 369.43 | 296.50 |
| Current trade debtors | 1 013.19 | 86.70 | 293.85 | 562.30 | 439.59 |
| Prepayments and accrued income | 99.34 | 48.98 | 19.10 | 20.82 | 20.09 |
| Current other receivables | 81.43 | 80.64 | 261.88 | 71.31 | 95.42 |
| Current deferred tax assets | 48.10 | 185.20 | 162.16 | 117.51 | |
| Short term receivables total | 1 193.96 | 264.43 | 760.03 | 816.59 | 672.62 |
| Cash and bank deposits | 2 306.35 | 6 139.38 | 4 343.84 | 2 547.65 | 1 270.87 |
| Cash and cash equivalents | 2 306.35 | 6 139.38 | 4 343.84 | 2 547.65 | 1 270.87 |
| Balance sheet total (assets) | 10 203.93 | 12 336.68 | 10 989.72 | 8 739.08 | 7 421.99 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 1 380.00 | 1 380.00 | 1 380.00 | 1 380.00 | 1 380.00 |
| Shares repurchased | 3 000.00 | ||||
| Retained earnings | - 437.06 | 2 897.50 | 3 349.12 | 3 474.41 | 3 389.77 |
| Profit of the financial year | 3 334.56 | 451.62 | 125.29 | -84.64 | - 210.01 |
| Shareholders equity total | 7 277.50 | 4 729.12 | 4 854.41 | 4 769.77 | 4 559.75 |
| Provisions | 71.00 | 60.00 | 60.00 | 34.00 | |
| Non-current other liabilities | 40.66 | 145.99 | 145.99 | ||
| Non-current deferred tax liabilities | 145.99 | 145.99 | |||
| Non-current liabilities total | 40.66 | 145.99 | 145.99 | 145.99 | 145.99 |
| Current loans from credit institutions | 60.70 | ||||
| Advances received | 188.82 | 206.51 | 237.86 | 222.57 | 223.35 |
| Current trade creditors | 1 263.05 | 787.20 | 1 071.46 | 1 258.15 | 1 450.99 |
| Short-term deferred tax liabilities | 15.04 | ||||
| Other non-interest bearing current liabilities | 1 287.17 | 6 407.86 | 4 620.00 | 2 308.60 | 1 041.91 |
| Current liabilities total | 2 814.77 | 7 401.57 | 5 929.32 | 3 789.32 | 2 716.24 |
| Balance sheet total (liabilities) | 10 203.93 | 12 336.68 | 10 989.72 | 8 739.08 | 7 421.99 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.